IBDEI10W ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16634,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
;;^UTILITY(U,$J,358.3,16634,1,4,0)
;;=4^D51.0
;;^UTILITY(U,$J,358.3,16634,2)
;;=^5002284
;;^UTILITY(U,$J,358.3,16635,0)
;;=D51.1^^61^775^209
;;^UTILITY(U,$J,358.3,16635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16635,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
;;^UTILITY(U,$J,358.3,16635,1,4,0)
;;=4^D51.1
;;^UTILITY(U,$J,358.3,16635,2)
;;=^5002285
;;^UTILITY(U,$J,358.3,16636,0)
;;=D51.9^^61^775^211
;;^UTILITY(U,$J,358.3,16636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16636,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,16636,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,16636,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,16637,0)
;;=D68.0^^61^775^213
;;^UTILITY(U,$J,358.3,16637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16637,1,3,0)
;;=3^Von Willebrand's Disease
;;^UTILITY(U,$J,358.3,16637,1,4,0)
;;=4^D68.0
;;^UTILITY(U,$J,358.3,16637,2)
;;=^127267
;;^UTILITY(U,$J,358.3,16638,0)
;;=C88.0^^61^775^214
;;^UTILITY(U,$J,358.3,16638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16638,1,3,0)
;;=3^Waldenstrom Macroglobulinemia
;;^UTILITY(U,$J,358.3,16638,1,4,0)
;;=4^C88.0
;;^UTILITY(U,$J,358.3,16638,2)
;;=^5001748
;;^UTILITY(U,$J,358.3,16639,0)
;;=C91.02^^61^775^3
;;^UTILITY(U,$J,358.3,16639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16639,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,16639,1,4,0)
;;=4^C91.02
;;^UTILITY(U,$J,358.3,16639,2)
;;=^5001764
;;^UTILITY(U,$J,358.3,16640,0)
;;=C92.02^^61^775^6
;;^UTILITY(U,$J,358.3,16640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16640,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,16640,1,4,0)
;;=4^C92.02
;;^UTILITY(U,$J,358.3,16640,2)
;;=^5001791
;;^UTILITY(U,$J,358.3,16641,0)
;;=D09.3^^61^775^50
;;^UTILITY(U,$J,358.3,16641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16641,1,3,0)
;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
;;^UTILITY(U,$J,358.3,16641,1,4,0)
;;=4^D09.3
;;^UTILITY(U,$J,358.3,16641,2)
;;=^5001955
;;^UTILITY(U,$J,358.3,16642,0)
;;=C22.0^^61^775^91
;;^UTILITY(U,$J,358.3,16642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16642,1,3,0)
;;=3^Hepatocellular Carcinoma
;;^UTILITY(U,$J,358.3,16642,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,16642,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,16643,0)
;;=C24.9^^61^775^118
;;^UTILITY(U,$J,358.3,16643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16643,1,3,0)
;;=3^Malig Neop Biliary Tract,Unspec
;;^UTILITY(U,$J,358.3,16643,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,16643,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,16644,0)
;;=C50.922^^61^775^142
;;^UTILITY(U,$J,358.3,16644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16644,1,3,0)
;;=3^Malig Neop Left Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,16644,1,4,0)
;;=4^C50.922
;;^UTILITY(U,$J,358.3,16644,2)
;;=^5133340
;;^UTILITY(U,$J,358.3,16645,0)
;;=C34.91^^61^775^160
;;^UTILITY(U,$J,358.3,16645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16645,1,3,0)
;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
;;^UTILITY(U,$J,358.3,16645,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,16645,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,16646,0)
;;=C50.921^^61^775^164
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10W 3773 printed Sep 23, 2025@19:35:34 Page 2
IBDEI10W ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16634,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,16634,1,3,0)
+4 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
+5 ;;^UTILITY(U,$J,358.3,16634,1,4,0)
+6 ;;=4^D51.0
+7 ;;^UTILITY(U,$J,358.3,16634,2)
+8 ;;=^5002284
+9 ;;^UTILITY(U,$J,358.3,16635,0)
+10 ;;=D51.1^^61^775^209
+11 ;;^UTILITY(U,$J,358.3,16635,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,16635,1,3,0)
+14 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
+15 ;;^UTILITY(U,$J,358.3,16635,1,4,0)
+16 ;;=4^D51.1
+17 ;;^UTILITY(U,$J,358.3,16635,2)
+18 ;;=^5002285
+19 ;;^UTILITY(U,$J,358.3,16636,0)
+20 ;;=D51.9^^61^775^211
+21 ;;^UTILITY(U,$J,358.3,16636,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,16636,1,3,0)
+24 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
+25 ;;^UTILITY(U,$J,358.3,16636,1,4,0)
+26 ;;=4^D51.9
+27 ;;^UTILITY(U,$J,358.3,16636,2)
+28 ;;=^5002289
+29 ;;^UTILITY(U,$J,358.3,16637,0)
+30 ;;=D68.0^^61^775^213
+31 ;;^UTILITY(U,$J,358.3,16637,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,16637,1,3,0)
+34 ;;=3^Von Willebrand's Disease
+35 ;;^UTILITY(U,$J,358.3,16637,1,4,0)
+36 ;;=4^D68.0
+37 ;;^UTILITY(U,$J,358.3,16637,2)
+38 ;;=^127267
+39 ;;^UTILITY(U,$J,358.3,16638,0)
+40 ;;=C88.0^^61^775^214
+41 ;;^UTILITY(U,$J,358.3,16638,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,16638,1,3,0)
+44 ;;=3^Waldenstrom Macroglobulinemia
+45 ;;^UTILITY(U,$J,358.3,16638,1,4,0)
+46 ;;=4^C88.0
+47 ;;^UTILITY(U,$J,358.3,16638,2)
+48 ;;=^5001748
+49 ;;^UTILITY(U,$J,358.3,16639,0)
+50 ;;=C91.02^^61^775^3
+51 ;;^UTILITY(U,$J,358.3,16639,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,16639,1,3,0)
+54 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
+55 ;;^UTILITY(U,$J,358.3,16639,1,4,0)
+56 ;;=4^C91.02
+57 ;;^UTILITY(U,$J,358.3,16639,2)
+58 ;;=^5001764
+59 ;;^UTILITY(U,$J,358.3,16640,0)
+60 ;;=C92.02^^61^775^6
+61 ;;^UTILITY(U,$J,358.3,16640,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,16640,1,3,0)
+64 ;;=3^Acute Myeloblastic Leukemia,In Relapse
+65 ;;^UTILITY(U,$J,358.3,16640,1,4,0)
+66 ;;=4^C92.02
+67 ;;^UTILITY(U,$J,358.3,16640,2)
+68 ;;=^5001791
+69 ;;^UTILITY(U,$J,358.3,16641,0)
+70 ;;=D09.3^^61^775^50
+71 ;;^UTILITY(U,$J,358.3,16641,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,16641,1,3,0)
+74 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
+75 ;;^UTILITY(U,$J,358.3,16641,1,4,0)
+76 ;;=4^D09.3
+77 ;;^UTILITY(U,$J,358.3,16641,2)
+78 ;;=^5001955
+79 ;;^UTILITY(U,$J,358.3,16642,0)
+80 ;;=C22.0^^61^775^91
+81 ;;^UTILITY(U,$J,358.3,16642,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,16642,1,3,0)
+84 ;;=3^Hepatocellular Carcinoma
+85 ;;^UTILITY(U,$J,358.3,16642,1,4,0)
+86 ;;=4^C22.0
+87 ;;^UTILITY(U,$J,358.3,16642,2)
+88 ;;=^5000933
+89 ;;^UTILITY(U,$J,358.3,16643,0)
+90 ;;=C24.9^^61^775^118
+91 ;;^UTILITY(U,$J,358.3,16643,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,16643,1,3,0)
+94 ;;=3^Malig Neop Biliary Tract,Unspec
+95 ;;^UTILITY(U,$J,358.3,16643,1,4,0)
+96 ;;=4^C24.9
+97 ;;^UTILITY(U,$J,358.3,16643,2)
+98 ;;=^5000942
+99 ;;^UTILITY(U,$J,358.3,16644,0)
+100 ;;=C50.922^^61^775^142
+101 ;;^UTILITY(U,$J,358.3,16644,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,16644,1,3,0)
+104 ;;=3^Malig Neop Left Male Breast,Unspec Site
+105 ;;^UTILITY(U,$J,358.3,16644,1,4,0)
+106 ;;=4^C50.922
+107 ;;^UTILITY(U,$J,358.3,16644,2)
+108 ;;=^5133340
+109 ;;^UTILITY(U,$J,358.3,16645,0)
+110 ;;=C34.91^^61^775^160
+111 ;;^UTILITY(U,$J,358.3,16645,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,16645,1,3,0)
+114 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
+115 ;;^UTILITY(U,$J,358.3,16645,1,4,0)
+116 ;;=4^C34.91
+117 ;;^UTILITY(U,$J,358.3,16645,2)
+118 ;;=^5000967
+119 ;;^UTILITY(U,$J,358.3,16646,0)
+120 ;;=C50.921^^61^775^164
